What's happened
A study shows a significant increase in postpartum women using GLP-1 drugs from 2018 to 2024, with nearly 2% now prescribed these medications. Most women are over 30, overweight, and have multiple children, despite no prior use or diabetes. The rise is unexpected during hormonal changes after childbirth.
What's behind the headline?
The sharp rise in postpartum GLP-1 prescriptions signals a shift in medical practice and societal attitudes toward weight management. This trend could be driven by increased awareness of obesity risks and the desire for quick weight loss solutions. However, the unexpected use during hormonal fluctuations raises concerns about safety and efficacy. The fact that most women had no prior health issues suggests a potential overreach in prescribing, possibly influenced by broader societal pressures around body image. The study's findings challenge the assumption that postpartum weight loss is solely hormonal and natural, indicating that medical intervention is becoming more common. Long-term impacts remain uncertain, and further research is needed to understand the implications of this trend for maternal health and healthcare practices.
What the papers say
The New York Times reports that prescriptions for GLP-1 drugs among postpartum women increased from fewer than five per 10,000 in 2018 to 173 per 10,000 in 2024, with most women over 30 and having multiple children. The study, published in JAMA Network Open, highlights that these women did not have diabetes or prior drug use, making the rise unexpected. Meanwhile, the broader context involves societal shifts toward weight management and the medical community's evolving approach to postpartum care. Experts like Mette Bliddal emphasize the need for cautious interpretation, noting that most women did not have indications for these drugs before, and the long-term safety during hormonal changes is unclear. The increase raises questions about prescribing practices and the influence of societal pressures on postpartum women seeking quick weight loss solutions.
How we got here
The use of GLP-1 drugs, originally for diabetes and weight management, has increased among postpartum women, a group typically experiencing natural weight loss. The rise may reflect broader trends in obesity and weight control, but the increase in prescriptions during a hormonal transition period is notable. Researchers highlight that most women did not have prior indications for these drugs, raising questions about prescribing practices and long-term effects.
Go deeper
More on these topics